Literature DB >> 11677658

Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation.

S J Chmura1, N Gupta, S J Advani, D W Kufe, R R Weichselbaum.   

Abstract

Ionizing radiation (IR) has been extensively used to treat a variety of solid tumors to improve local control and overall survival in patients. Gene therapy strategies represent one experimental direction to improve radiocurability. These gene therapy strategies include (1) replacement of mutated or deleted tumor-suppressor genes, (2) delivery of prodrugs, (3) transduction of genes under the control of radiation-inducible promoters, and (4) genetically engineered viruses that replicate preferentially in tumor cells after IR. Although any one of these viral-based gene therapy approaches is unlikely to succeed independently, experimental results suggest that clinically important antitumor can be achieved when these strategies are combined with IR. Several of these strategies are currently being or soon will be evaluated in clinical trials. This review focuses on molecular mechanisms and potential clinical application of these viral-based gene therapy strategies to improve the therapeutic index of IR. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677658     DOI: 10.1053/srao.2001.26019

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  3 in total

1.  Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy.

Authors:  Sheng-Nan Jiang; Thuy X Phan; Taek-Keun Nam; Vu H Nguyen; Hyung-Seok Kim; Hee-Seung Bom; Hyon E Choy; Yeongjin Hong; Jung-Joon Min
Journal:  Mol Ther       Date:  2010-01-05       Impact factor: 11.454

2.  Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria.

Authors:  Chetan Bettegowda; Long H Dang; Ross Abrams; David L Huso; Larry Dillehay; Ian Cheong; Nishant Agrawal; Scott Borzillary; J Michael McCaffery; E Latice Watson; Kuo-Shyan Lin; Fred Bunz; Kwamena Baidoo; Martin G Pomper; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.

Authors:  Vladimir L Sukhorukov; Michael Flentje; Cholpon S Djuzenova; Thomas Fischer; Astrid Katzer; Dmitri Sisario; Tessa Korsa; Gudrun Steussloff
Journal:  BMC Cancer       Date:  2021-11-11       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.